Jg. Dobbins et al., Herpes in the time of AIDS: A comparison of the epidemiology of HIV-1 and HSV-2 in young men in northern Thailand, SEX TRA DIS, 26(2), 1999, pp. 67-74
Objectives: To compare the epidemiologic pattern of HIV-1, a recently intro
duced sexually transmitted disease (STD) agent in Thailand, with the patter
n of HSV-2, a well-established STD agent, so that future trends for both vi
ruses can be better understood.
Methods: We obtained questionnaire data and determined HSV-2 (by specific g
G-2) and HIV-1 seroreactivity in a cohort of 1,115 young male army conscrip
ts who entered service in northern Thailand in 1991,
Results: Seroprevalence of HIV-1 and HSV-2 was 6.9% and 14.9%, respectively
, For HSV-2-seropositive men who reported previous genital ulcers, HIV-1 se
roprevalence was 32%. For most variables, there was a close correspondence
between the prevalence ratios for HIV-I and for HSV-2, except that prevalen
ce ratios for HIV-1 tended to be greater than the corresponding ratios for
HSV-2, The seroprevalence of both viruses was strongly related to early and
frequent contact with female sex workers (FSWs), infrequent use of condoms
with FSWs, and residence in the upper north region of Thailand, When diffe
rences in sexual behavior between the upper north and lower north were cont
rolled for, the seroprevalence of both viruses still differed significantly
by region.
Conclusions: Although the seroprevalence levels of HSV-2 and HIV-1 were qui
te different in this cohort of Thai army conscripts in 1991, the patterns o
f infection in terms of demographic, residential, and behavioral variables
were similar. Seroprevalence studies of HSV-2 in other populations, particu
larly where the HIV-1 epidemic is just beginning, may be useful in predicti
ng which subgroups might be most vulnerable to the epidemic and could there
fore benefit the most from public health intervention. Where differences in
the patterns of the two viruses have been noted, we hypothesize that the p
attern for HIV-1 will evolve toward that seen for HSV-2.